BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11264777)

  • 1. Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis.
    Jaradat MI; Moe SM
    Semin Dial; 2001; 14(2):107-12. PubMed ID: 11264777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F
    Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontransplant therapy for dialysis-related amyloidosis.
    Copley JB; Lindberg JS
    Semin Dial; 2001; 14(2):94-8. PubMed ID: 11264774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the nephrologist prevent dialysis-related amyloidosis?
    Zingraff J; Drüeke T
    Am J Kidney Dis; 1991 Jul; 18(1):1-11. PubMed ID: 2063840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new therapeutic approach to dialysis amyloidosis: intensive removal of beta 2-microglobulin with adsorbent column.
    Gejyo F; Homma N; Hasegawa S; Arakawa M
    Artif Organs; 1993 Apr; 17(4):240-3. PubMed ID: 8498903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?
    Schwalbe S; Holzhauer M; Schaeffer J; Galanski M; Koch KM; Floege J
    Kidney Int; 1997 Oct; 52(4):1077-83. PubMed ID: 9328948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorption of beta 2-microglobulin on dialysis membranes: comparison of different dialyzers and effects of reuse procedures.
    Goldman M; Lagmiche M; Dhaene M; Amraoui Z; Thayse C; Vanherweghem JL
    Int J Artif Organs; 1989 Jun; 12(6):373-8. PubMed ID: 2674020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 11. Dialysis-related amyloidosis and clinical significance of extracorporeal removal of beta2-microglobulin.
    Gejyo F; Suzuki S; Arakawa M
    Ther Apher; 1997 May; 1(2):126-8. PubMed ID: 10225756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-2-microglobulin-associated amyloidosis in chronic hemodialysis patients with carpal tunnel syndrome.
    Ullian ME; Hammond WS; Alfrey AC; Schultz A; Molitoris BA
    Medicine (Baltimore); 1989 Mar; 68(2):107-15. PubMed ID: 2646507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavior of beta 2-microglobulin (B2-m) serum levels in uremic patients.
    Mioli VA; Balestra E; Bibiano L; Dellabella S; Fanciulli E; Gaffi G; Perilli A; Petroselli F; Ricciatti AM; Carletti P
    Int J Artif Organs; 1994 Nov; 17(11):576-80. PubMed ID: 7744516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes.
    Campistol JM; Torregrosa JV; Ponz E; Fenollosa B
    Contrib Nephrol; 1999; 125():76-85. PubMed ID: 9895432
    [No Abstract]   [Full Text] [Related]  

  • 16. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
    Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
    Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do different dialysis-membranes affect beta 2-microglobulin kinetics during chronic hemodialysis?
    Risler T; Braun N; Hanel KD; Kuhlmann U; Skroch D; Müller GA
    Int J Artif Organs; 1994 Nov; 17(11):581-4. PubMed ID: 7744517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 2-microglobulin amyloidosis in chronic dialysis patients: a case report and review of the literature.
    Farrell J; Bastani B
    J Am Soc Nephrol; 1997 Mar; 8(3):509-14. PubMed ID: 9071720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results.
    David S; Cambi V
    Contrib Nephrol; 1999; 125():96-110. PubMed ID: 9895434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.